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Available online 22 April 2014Abstract Androgen-deprivation is a mainstay of therapy for advanced prostate cancer but tumor regression is usually incomplete
and temporary because of androgen-independent cells in the tumor. It has been speculated that these tumor cells resemble the
stem/progenitor cells of the normal prostate. The purpose of this studywas to examine the response of slow-cycling progenitor cells
in the adult mouse prostate to castration. Proliferating cells in the E16 urogenital sinuswere pulse labeled by BrdU administration or
by doxycycline-controlled labeling of the histone-H2B GFPmouse. A small population of labeled epithelial cells in the adult prostate
localized at the junction of the prostatic ducts and urethra. Fluorescence-activated cell sorting (FACS) showed that GFP
label-retaining cells were enriched for cells co-expressing stem cell markers Sca-1, CD133, CD44 and CD117 (4- marker cells; 60-fold
enrichment). FACS showed, additionally, that 4-marker cells were androgen receptor positive. Castration induced proliferation and
dispersal of E16 labeled cells into more distal ductal segments. When naïve adult mice were administered BrdU daily for 2 weeks
after castration, 16% of 4-marker cells exhibited BrdU label in contrast to only 6% of all epithelial cells (P b 0.01). In sham-castrated
controls less than 4% of 4-marker cells were BrdU labeled (P b 0.01). The unexpected and admittedly counter-intuitive finding that
castration induced progenitor cell proliferation suggests that androgen deprivation therapy in men with advanced prostate cancer
could not only exert pleiotrophic effects on tumor sub-populations but may induce inadvertent expansion of tumor stem cells.
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Before embryonic day 16 (E16), the UGS is comprised of an
outer layer of mesenchyme surrounding an inner epithelial
layer from which outgrowth occurs to form the prostate ducts
(Price, 1963; Wang et al., 2001). At E16.5–17.5 epithelial buds
invade the surrounding mesenchyme and begin the process of
ductal morphogenesis that generates the complex ductal
structure of the adult prostate (Sugimura and Donjacour,n access article under the CC BY-NC-ND license
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mouse prostate has distinct anterior, dorsal–lateral and
ventral lobes; each lobe is divided into proximal, intermedi-
ate and distal regions based on their relative location to the
urethra (Salm et al., 2005; Cunha et al., 1987). Prostate
development is androgen dependent and involves intimate
signaling between epithelial and mesenchymal cells. Mainte-
nance of the adult prostate is also androgen-dependent, and
the prostate undergoes rapid involution following castration.
This involves epithelial apoptosis concentrated in the distal
duct segments, loss of androgen-dependent differentiation in
the remaining epithelium and remodeling of the periductal
stroma (Sugimura and Donjacour, 1986). This process is
completely reversed by androgen supplement. The castra-
tion–regeneration cycle can repeat for many rounds without
observable defects in the regenerated prostate (Sugimura and
Donjacour, 1986). This observation suggested the presence of a
progenitor cell population in the adult prostate capable of
surviving androgen deprivation and sufficient to regenerate the
ductal segments of the intact adult prostate.
Adult tissue progenitor cells possessing the ability for self-
renewal and/or generation of lineage-committed cells are
generally quiescent cells recruited into active proliferation
during tissue regeneration and repair (Morrison and Spradling,
2008; Knoblich, 2008). The generally ‘slow cycling’ property
of these cells has permitted localization by 3H thymidine,
5-bromo-2′-deoxyuridine (BrdU) and histone H2B-green fluo-
rescent protein (GFP) labeling methods in a variety of tissues,
such as mammary gland, hair follicles, small intestine, and
cornea (Cotsarelis et al., 1989; Tani et al., 2000; Taylor et al.,
2000; Berardi et al., 1995; Thorgeirsson, 1996; Tsujimura et
al., 2002). The regenerative capacity of the prostate has been
attributed to the existence of progenitor cells in the adult
gland that survive castration-induced involution (Kinbara et
al., 1996; Robinson et al., 1996; Hudson et al., 2000; Collins et
al., 2001; Foster et al., 2002). Several lines of evidence suggest
that these progenitor cells reside within the proximal region of
the prostate ducts. When adolescent mice were BrdU labeled
and then subjected to multiple rounds of castration and
testosterone supplementation to ‘wash out’ the BrdU label in
dividing cells, the ‘slow cycling’ label-retaining cells were
concentrated in the proximal duct segments (Tsujimura et al.,
2002). In another set of experiments it was demonstrated that
cells from the proximal duct have higher tissue regenerative
ability when grafted under the renal capsule of recipient host
animals (Burger et al., 2005; Xin et al., 2005). The studies
reported here build upon those previous observations. We
localize a slow-cycling cell population enriched for stem cell
markers to the proximal duct segments and show the surprising
and clinically important observation that castration induces
these cells to proliferate andmigrate tomore distal sites in the
ductal network.
Materials and methods
Animal maintenance and tissue recovery
Wild-type and nude CD-1 mice were purchased from
Charles River Laboratories (Wilmington, MA). The trans-
genic mouse line expressing the histone H2B-green flores-
cent protein (H2B-GFP) under the control of tetracycline-responsive element (Tumbar et al., 2004) was from Jackson
Laboratories (Bar Harbor, ME); the mouse line expressing
tetracycline responsive element under the control of CK5
promoter (tTA) was a generous gift from Adam B. Glick lab
(Diamond et al., 2000). At the appropriate time prostates
were harvested and analyzed for the presence of label
retaining cells. The isolated prostate tissue was either
enzymatic digested to single cells for FACS analysis or
fixed in 10% neutral buffered formalin for embedding and
sectioning.
All animal procedures were performed in accordance
with institutional guidelines and approval by the Animal
Care and Use Committee at the University of Wisconsin-
Madison.
BrdU label retaining cells
To produce BrdU label-retaining cells labeled at E16, we
injected (IP) pregnant dams at E16 with 0.5 ml of 50 mM
BrdU in PBS. We found that a single injection of BrdU was
sufficient to mark cells in the developing prostate, while at
10 weeks of age still retaining a small fraction of those
cells.
GFP label retaining cells
To control for expression of GFP in the H2B-GFP pulse-chase
experiments, the pregnant dam was fed a diet containing
doxycycline from before conception until E15.5 at which time
the diet was changed to a standard feed without doxycycline
for 24 h after which the diet wasmaintained on the doxycycline
containing feed until the animals were harvested. This 24-hour
period of GFP expression was sufficient to label many cells and
provide a population of label retaining cells in the adult animals
at 10 weeks of age.
Castration
To determine the fate of the label retaining cells following
androgen withdrawal we castrated animals, under an approved
protocol, at 8 weeks of age and allowed them to recover for up
to 14 days at which time the animals were sacrificed and
prostates were harvested.
Renal capsule graft
Rat urogenital sinus mesenchyme (rUGM) was isolated from
1% trypsin digested E18 rat urogenital sinus. A single cell
suspension of UGM was collected after 0.5% collagenase
digestion. FACS sorted 4-marker+ or 4-marker− cells (1000
each) were mixed with 25,000 UGM cells and resuspended in
15 μl of type I collagen (BD biosciences, Bedford, MA), and
implanted under the renal capsule of athymic nude mice as
described (Tsujimura et al., 2002).
Histology
Dissected prostate tissues or renal grafts were fixed in 10%
formaldehyde for 12 h at 4 °C, appropriately orientated and
embedded in 4% agarose. The samples were then sectioned at
156 X. Shi et al.200 μm in thickness with a vibratome. The vibratome sections
were processed, paraffin embedded and sectioned. The 5 μm
paraffin sections were dewaxed, and stained with Mayer's
hematoxylin and eosin (H&E) for histological evaluation.
Indirect immunofluorescent staining
Dewaxed sections were used for antigen retrieval which was
performed in the citrate buffer and heated in the microwave
oven for 30 to 50 min at 95% power. The tissue sections were
blockedwith 3% BSA in PBS plus 10% normal donkey serum. The
primary antibodies used were: rabbit anti-androgen receptor
(Santa Cruz, Dallas, Texas); rat anti-Ki67 (Dako North
America, Carpinteria, CA); and mouse anti-BrdU (Roche USA,
Nutley, NJ). The secondary antibodies were from Molecular
Probes (Eugene, Oregon). Following primary antibody incuba-
tion, the sections were washed with PBS, and the secondary
antibody was applied at 1:200 at room temperature for 1 h.
Then sections were washed with PBS and counter stained
with 4′,6-diamidino-2-phenylindole (DAPI). Fluorescent
images were captured using an Olympus-BX51 fluorescent
microscope (Olympus, Center Valley, PA) with a digital
camera and SPOT advanced software or BD Pathway
bioimaging systems (BD Biosciences, San Jose, CA).
FACS analysis of H2B-GFP label retaining cells for the
stem cell markers (Sca-1, CD133, CD44 and CD117)
H2B-GFPmice weremated with K5-Tet (tTA, Tet off) mice and
genotyped. Mice that were positive for both GFP and K5-Tet
were used for experiments and double negative littermates
were used as control. The prostate tissue was dissected from
10-week old mice in cold PBS under a dissecting microscope.
The tissue was minced into 2–3 mm pieces and digested by
collagenase and hyaluronidase (Stemcell Technologies, Inc.,
Vancouver, BC, Canada; Cat. No. 07912) at 37 °C for 3 h. This
digestion was followed by a second digestion in 0.25% trypsin/
EDTA in 2% BSA on ice for 30 min according to instructions
(Stemcell Technologies, Inc., Vancouver, BC, Canada). We
found that digestion with 0.25% trypsin on ice for 30 min
increased yield of single cells from prostate tissue without
affecting FACS analysis of stem cell markers. The digested
cells were passed through a 40 μm cell strainer to isolate
single cells with an aliquot of cells used to determine cell
concentration and checked for viability by trypan blue
staining. Single cells were treated with a mouse lineage
depletion kit according to instructions (Miltenyi Biotec Inc.,
Auburn, CA). The lineage depleted cells (Lin−) then suspended
in DMEM (Mediatech, Manassas, VA) containing 5% FBS followed
by addition of primary antibodies directly coupled to specific
fluorochromes (Sca-1, CD133, CD44 and CD117 as previously
reported (Leong et al., 2008) for 30 min on ice. DAPI was
added to the cell suspension prior to FACS analysis to select
viable cells. Single stem cell maker stained cells and isotype
matched IgG were used to identify positive and negative
signal. Fluorescence-minus-one (FMO) controls were used to
determine gating in multicolor flow cytometry. FACS analysis
was performed on a BD LSR-II flow cytometry (BD Biosciences,
San Jose, CA). The cells were gated for single events and
viability. The flow cytometry data was analyzed using
FlowJo8.6 software. The relationship between GFP positivelabel retaining cells and stem cell marker expression was
analyzed statistically.
FACS analysis of progenitor cell proliferation after
castration by correlating of BrdU labeling and stem
cell marker expression
Adult (8 week old) CD-1 mice were divided into 4 groups:
Sham-BrdU, Sham-PBS, castration-BrdU and castration-PBS.
500 μl of 10 mM BrdU (Sigma, MO) was given by IP injection
to castrated or sham mice daily for 14 days starting at the
time of castration and 500 μl PBS was injected as control.
On day 14 the prostate was processed and stained for the
four stem cell markers as described above. After staining
with antibodies to stem cell markers, the cells were fixed
and stained with a BrdU Flow Kit (BD Bioscience, San Jose)
as instructed. FACS analysis was performed as described
above for the 4-markers and BrdU after gating for single
events.
Quantitative and statistical analysis of the
relationship between label retaining cells and other
cell markers
The percentage of BrdU positive cells were determined by
BrdU positive cells over the total cells of interest. Each group
has 3–5 animals, and the paraffin embedded prostate tissue
from each animal was completely sectioned, and 5 sections
were used for analysis. At least 10 of 200× high power field
(HPF) images from each section were included in the analysis.
Statistical analysis was conducted using one-way analysis of
variance (ANOVA) and values were presented as mean ± SEM
derived from at least three independent experiments, unless
otherwise stated. The ANOVAwas followed by Tukey's post hoc
test. P value less than 0.05 was regarded as statistically
significant. Statistical analysis of IHC data was performedwith
assistance from the UW Madison Department of Surgery's
Statistical Core.
Results
Prenatal BrdU labeling yields label-retaining cells in
the proximal duct segments
Previous studies have identified slow-cycling epithelial cells
in the adult prostate by BrdU labeling during adolescence
followed by multiple rounds of castration-induced involution
and testosterone-induced re-growth. This approach yields
a relatively abundant population of labeled cells preferen-
tially localized to the proximal duct segments (Tsujimura et
al., 2002). We speculated that initiation of prostate ductal
budding (E16.5–17.5) would entail a robust expansion of
prostate tissue-specific stem cells, primitive progenitor cells
or both, and that pulse labeling with BrdU at E16 would yield
a rarified population of label-retaining cells in the adult
prostate that had remained mitotically quiescent since the
earliest stages of prostate development. Pregnant dams
were given a single dose of BrdU by intraperitoneal injection
at E16 and the male offspring sacrificed at 10 weeks of age.
The lower genitourinary tract was removed en bloc. The
Figure 1 Location of label retaining cells in the adult mouse prostate. (A) Wild-type CD-1 dams were injected with BrdU at E16 and
the male offspring were harvested at 10 weeks. Immunofluorescence staining localized BrdU label-retaining cells mostly to the
proximal duct segments and junction with the urethra (Montage image of the sagittal sections of prostate). (B–D) Boxed regions in
image A. (E) Distribution of LRCs in proximal, intermediate and distal regions (n = 5). (F) H2B-GFP mice were mated and GFP
expression from the cytokeratin 5 (CK5) promoter was activated in pregnant females for 24 h at E16 by removing doxycycline from the
water supply. The male offspring were harvested at 10 weeks, and fluorescence microscopy localized most GFP label-retaining cells
to CK5 (red) positive cells.
157Prostate progenitor cells proliferate in response to castrationprostate and urethra were fixed, serially sectioned and
immunostained for BrdU. We reproducibly observed a small
number of labeled epithelial cells located at the junction of
the prostatic main ducts and the urethra and in the proximal
ducts (Fig. 1). Epithelial labeling was confirmed by co-
staining with epithelial markers. Labeled epithelial cells were
rarely observed in intermediate and distal ducts. Note was
made of scattered BrdU-labeled stromal cells that were most
abundant in the region of the proximal ducts. Co-staining for
BrdU and Ki67 or Caspase 3 revealed a very low proliferative
index and rare instances of apoptosis among the labeled cells.
We conclude that pulse BrdU labeling at E16 yields a
population of slow-cycling labeled cells in the proximal duct
segments of the adult prostate.Prenatal CK-5/GFP labeling yields labeled cells in
the proximal duct segments
To corroborate this observation and facilitate FACS analysis
of stem cell marker expression, cytokeratin 5 (CK-5) express-
ing cells were selectively pulse labeled at E16 using a
doxycycline-controlled histone-H2B GFP mouse (Tumbar et
al., 2004). Histone labeling by this technique is effectively an
equivalent way of introducing label into proliferating cells
that is “washed out” by subsequent rounds of replication.
However, it has the advantage that the histone-H2B GFPlabeling is amenable to FACS analysis of living cells. The
labeling technique differs from BrdU labeling in that only
proliferating cells expressing CK5 are labeled with GFP. The
male offspring were sacrificed at 10 weeks of age and the
prostate and urethra were serially sectioned and imaged
by immunofluorescence microscopy. We again observed (GFP)
labeled epithelial cells localized to the proximal duct
segments and their urethral junction (Fig. 1F). Sca-1, CD133,
CD44 and CD117 have been implicated as prostate stem cell
markers since a single cell co-expressing these 4-markers
can generate fully differentiated prostate tissue when com-
bined with urogenital mesenchyme (Leong et al., 2008). FACS
analysis showed 6% of the GFP labeled cells in the 10 week
adult prostate co-expressed Sca-1, CD133, CD44 and CD117.
This contrasted with co-expression of these stem cell markers
in only ~0.1% of the total epithelial cell population (Fig. 2).
Further analysis showed that 26% of cells co-expressing Sca-1,
CD133, CD44 and CD117 were GFP positive even though GFP
label was present in only 1.5% of the total epithelial cell
population (Fig. 2). These data show that pulse GFP labeling
CK-5 expressing cells at E16 yields a population of label
retaining cells located in the proximal duct segments that
are significantly enriched for co-expression of prostate stem
cell markers and, indeed, account for over a quarter of all
co-expressing cells in the adult prostate.
It is intuitively obvious and commonly accepted that
prostate progenitor cells that participate in testosterone-
Figure 2 GFP labeling at E16 yields a population of labeled cells enriched for co-expression of stem cell markers. CK5/H2B-GFPmicewere
GFP-labeled at E16 and sacrificed at 10 weeks. Single cells were isolated by enzymatic digestion and lineage committed cells were depleted
for Lin− cells. FACS analysis of Lin− was performed for co-expression of Sca-1, CD133, CD44 and CD117 (n = 3). (A) Approximately 6% of GFP
positive cells co-expressed these 4 markers, while only 0.1% of the total cell populations co-expressed these 4 markers. (B) Approximately
26% of cells co-expressing these 4 markers were GFP positive, while only 1.5% of the total cell population was GFP positive. (C) Diagram of
sequential analysis of flow cytometry data. Cells from the prostate were isolated by magnetic beads to obtain Lin− cells. These cells were
gated by forward scatter (FSC) and side scatter (SSC). Then the cells were gated by DAPI exclusion (Lin− viable). Lin− viable cells were gated
byGFP expression to separateGFP+ andGFP− cells. GFP+ andGFP− cells were analyzed by sequential gating for Sca-l, CD133, CD44 and CD117
and the percentage of 4-marker positive cells in GFP+ and GFP− groups were determined.
158 X. Shi et al.induced regeneration of the castrated mouse prostate are not
dependent on androgen for survival. However, it has not been
established whether or not these cells express the androgen
receptor. We performed staining for androgen receptor (AR) inBrdU label retaining cells. Micewere BrdU pulse labeled at E16 as
described above and sacrificed at 10 weeks of age. Co-staining
for BrdU and androgen receptor (AR) revealed approximately 75%
of BrdU-labeled cells to be AR+ (Fig. 3A–B). This is less than the
Figure 3 The majority of prostate 4-marker cells stain positive for androgen receptor. CD-1 mice were BrdU labeled at E16 and
sacrificed at 10 weeks. Co-staining was performed for androgen receptor (AR) and BrdU. (A) A representative section of co-stained
prostate epithelium. (B) Quantitative analysis of co-staining for AR and BrdU in the prostate epithelium (n = 5). (C) Ten week old CD-1
mice were sacrificed and the epithelium was subjected to FACS analysis for AR, Sca-1, CD133, CD44 and CD117. Quantitative analysis
shows that most 4-marker cells are androgen receptor positive (n = 3).
159Prostate progenitor cells proliferate in response to castrationexpression of AR in 95% of the total epithelial cell population, but
the preponderance of AR expression in this population was
unexpected and prompted us to examine the expression of AR in
cells co-expressing Sca-1, CD133, CD44 and CD117. FACS analysis
was performed on intact adult mice: we observed that 99.7%
cells co-expressing Sca-1, CD133, CD44 and CD117 also express
AR (Fig. 3C).Label retaining cells proliferate after castration
Castration of the adult mouse induces widespread epithelial
apoptosis and glandular involution; however, several studiesFigure 4 BrdU labeled cells are dispersed post-castration. CD-1 mi
2 weeks after castration. (A) Immunostaining for BrdU labeled cells (Mo
analysis for the location of BrdU labeled cells (n = 5). (C and D) Boxed
(red) with CK5 (green) in non-proximal and proximal ducts.have shown that a low level of epithelial proliferation
persists even while glandular involution is occurring (Alison
et al., 1976; Evans and Chandler, 1987). To examine the
response of slow-cycling cells in the adult prostate to
castration, E16-BrdU labeled mice were castrated or sham
operated at 8 weeks of age and sacrificed 2 weeks later.
In sham-operated mice, we observed label retaining cells
located exclusively in the proximal duct segments and their
junction with the urethra (Fig. 1A–D). The labeled cells were
usually solitary; they were occasionally paired. In castrated
mice there was an increase in the total number of label
retaining cells and dispersal of labeled cells into the
non-proximal duct segments (Fig. 4). Most labeled cells ince BrdU labeled at E16 were castrated at 8 weeks and sacrificed
ntage image of the sagittal sections of prostate). (B) Quantitative
regions in A. (E and F) Colocalization of BrdU label-retaining cells
Figure 5 Castration induces proliferation of BrdU labeled cells. (A) Clusters of BrdU labeled cells (arrows) were observed in mice
labeled and castrated as described in Fig. 4. Similar clusters were never observed in the intact controls. Co-staining for BrdU and CK5
identified the cluster of labeled cells as basal cells. (B and C) Staining for Ki67 in mice labeled and castrated as described in Fig. 4
revealed increased proliferation of BrdU labeled cells. (B) Immunofluorescence staining for BrdU (red), Ki67 (green) and DAPI (blue)
shows co-localization of BrdU with Ki67. This is quite uncommon in intact controls. Quantitative analysis of co-staining for Ki67 and
BrdU confirms that co-staining is significantly increased in castrated animals (C) (n = 5).
160 X. Shi et al.the castrated mice were solitary; however, we frequently
observed clusters of labeled cells. Clusters were a unique
feature of the castrated mice (Fig. 5A). From this finding,
we inferred that label-retaining cells proliferate following
castration. This inference was confirmed by Ki67 staining
(Fig. 5B and C).
Castration induces a selective proliferation of cells
co-expressing stem cell markers
The observation that slow-cycling cells in the adult prostate
proliferate in response to castration was surprising and
prompted us to examine the behavior of cells co-expressing theFigure 6 Castration induces selective proliferation of 4-marker
castrated. BrdU was injected daily after surgery to label the prolife
(A) FACS analysis showed significantly higher labeling of 4-marker cel
independent experiments; Fig. 6A). These data signify increased p
(B) Proliferation was greater in 4-marker progenitor cells than that in n
Taken together, these data indicate that castration induces preferentstem cell markers Sca-1, CD133, CD44 and CD117. Adult males
were castrated or sham operated and then administered BrdU
daily by injection for 2 weeks. The prostates from sham-
operated and castrated mice were harvested, enzymatically
digested to single cells and subjected to FACS analysis to
determine the proportion of BrdU labeling in cells co-expressing
the stem cell markers Sca-1, CD133, CD44 and CD117. This
analysis revealed a selective expansion of 4-marker cells
following castration. We observed a significantly higher
percentage of BrdU+ 4-marker cells in the castrated versus
sham operated mice (16% versus 3.7%; Fig. 6A). This finding
indicates that castration increases proliferation of the
4-marker positive cell population. To distinguish a selectiveprogenitor cells. Eight week old mice were sham operated or
rating cells, and mice were sacrificed 2 weeks after castration.
ls in the castrated versus sham operated mice (16% versus 3.7%; 3
roliferation of 4-marker cells in the castrated mouse prostate.
on-4-marker positive cells in the castrated prostate group (n = 3).
ial proliferation of 4-marker cells.
161Prostate progenitor cells proliferate in response to castrationincrease in progenitor cell proliferation from a generalized
increase in epithelial proliferation, we compared labeling
indices between 4-marker cells and the remainder. We
found that 16% of cells co-expressing the four stem cell
markers were BrdU+ whereas only 6% of the remaining
epithelial cells were BrdU+ (Fig. 6B) in the castrated group.Discussion
Epithelial proliferation is concentrated at the tips of the
developing prostate ducts and early studies focused on the
duct tip as the probable site of progenitor/stem cells
(Kinbara et al., 1996). Subsequent studies examining label
retention and regenerative capacity implicated the proximal
duct as the reservoir of stem/progenitor cells in the adult
prostate (Tsujimura et al., 2002; Kinbara et al., 1996; Burger
et al., 2005; Xin et al., 2005). Further studies sorting for
putative stem cell markers and testing for regenerative
potential confirmed a relative abundance of stem cells in
the proximal duct as compared to the intermediate and
distal duct segments (Evans and Chandler, 1987; Lawson et
al., 2007; Burger et al., 2005; Xin et al., 2005). Labeling with
either BrdU or GFP at the onset of ductal budding yielded
a small population of labeled cells in the adult prostate
concentrated in the proximal ducts near their urethral origin. In
our study, we also observed label-retaining stromal cells
localized to the stromal compartment surrounding the proximal
ducts. This could be coincidence, but it does suggest the
possibility that slow-cycling epithelial and stromal cells are
co-localized within a specific niche in the adult gland and share
regulatory signaling mechanisms (Goto et al., 2006; Potten and
Loeffler, 1990; Lavker and Sun, 2000). The most striking
findings were robust proliferation of these cells at E16, the
preponderance of AR gene expression and the proliferative
response to castration.
The ducts of the adult mouse prostate are lined by a
pseudostratified epithelium composed of basal cells, luminal
cells and rare neuroendocrine cells. The identity and
location of stem cells within this epithelial layer are still a
matter of debate. At one time basal cells were widely
believed to contain progenitor cells capable of differentiat-
ing into basal, luminal and neuroendocrine cells (Collins et
al., 2001; Wang et al., 2001). This view has been challenged
by recent observations suggesting that stem cells may
also reside in the luminal cell layer (Slack, 2000). Single
cells co-expressing the markers used in our studies (Lin−
Sca-1+CD133+CD44+CD117+) have been shown capable of
regenerating a fully differentiated prostate epithelium (Leong
et al., 2008). We found that GFP label retaining cells were
enriched for co-expression of Lin− Sca-1+CD133+CD44+
CD117+. While only a fraction of label retaining cells co-
expressed the four stem cell markers, they accounted for
approximately a quarter of all the cells co-expressing
these markers. This was unexpected and suggests that
initiation of prostate ductal budding is associated with a
uniquely robust proliferation of epithelial stem/progenitor
cells. This is to our knowledge the first evidence that
initiation of prostate organogenesis is accompanied by a
burst of proliferation among cells that will become a tissue
specific stem or progenitor cells in the adult organ. We
speculate that this proliferative burst potentially creates awindow of vulnerability of these reserve cells to mutation
or imprinting changes that could predispose to neoplasia in
the adult. Whether a similar burst of proliferation among
stem/progenitor cells in other developing organs remains
to be determined.
AR is present in the nucleus of most epithelial and
stromal cells of the intact adult prostate. Luminal cells
are predominantly, if not exclusively, androgen positive
whereas only half of all basal cells are (Wang et al., 2009). AR
in the stroma mediates paracrine stimulation of epithelial
proliferation while AR in epithelial cells stimulates luminal
cell differentiation and protein synthesis. It has been assumed
that prostate stem cells lack AR (Mirosevich et al., 1999);
however, there is some evidence to challenge this view as it
applies to the human prostate (Oldridge et al., 2012) and
the mouse prostate (Slack, 2000). We found that most BrdU
label retaining epithelial cells in the adult prostate were AR
positive. More striking was the observation that four-marker
positive cells are nearly all AR positive. Insofar as previous
studies showed that 14 in 97 four-marker positive cells
exhibit the regenerative capacity bona fide stem cells in a
tissue recombination assay (Leong et al., 2008), our data
suggests that at least some, if not all, stem cells are AR
positive.
AR has been shown to exert a growth inhibitory effect
in luminal cells. In transgenic mice lacking epithelial AR,
epithelial cells are less differentiated and hyper-proliferative
(Heer, 2011). It is possible that selective proliferation of
slow-cycling and 4-marker cells after castration reflects a
release of androgen-mediated inhibition of proliferation of
cells that do not require androgen for survival. There is
precedent for this in the breast where estrogen suppresses
stem cell proliferation (Wu et al., 2007). An alternative
explanation for proliferation and migration of LRCs and
4-marker cells following castration would be the response to
injury. Progenitor cells play a primary role in the regener-
ative response to injury in a variety of adult tissues (Simões
et al., 2011; Amcheslavsky et al., 2009; Imitola et al., 2004;
Brunt et al., 2010; Zhang et al., 2000) and it has been
postulated that factors released by injured tissues stimulate
stem cell proliferation and attract stem cells to the sites of
injury (Crosnier et al., 2006; Inui and Sakaguchi, 1992). The
effects of castration on the adult prostate are a combina-
tion of ischemic injury due to vascular disruption, epithelial
apoptosis and acute inflammation (Bodine, 1995; Hayek et
al., 1999; Kerr and Searle, 1973). Whether a direct response
to decreased testosterone levels or in response to castration-
induced injury, our observation may be relevant to the
behavior of tumor stem cells in prostate cancer. To the
extent that tumor stem cells phenocopy the features of
normal adult stem/progenitor cells, our findings suggest
that treatment of human prostate cancer with androgen
deprivation could inadvertently produce an expansion of
tumor stem cells.Appendix A. Supplementary dataSupplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2014.04.005.
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